Androgenetic Alopecia Manufacturers and Market Growth
The global androgenetic alopecia market size was estimated at US$ 2.98 billion in 2023 and is projected to grow to US$ 7.31 billion by 2034, rising at a compound annual growth rate (CAGR) of 8.49% from 2024 to 2034.
Top Companies in the Androgenetic Alopecia:
- Theradome Inc.
- Apira Science, Inc. (iGROW Laser)
- Curallux, LLC
- Freedom Laser Therapy, Inc. (iRESTORE Hair Growth System)
- Lexington Intl., LLC
- Aurobindo Pharma
- Dr. Reddy’s Laboratories Ltd.
- Merck & Co., Inc.
- Sun Pharmaceutical Industries Ltd.
- Cipla, Inc.
- Johnson & Johnson Services, Inc.
Recent Announcements by Industry Leaders
Developing new medicines to cure androgenic alopecia (hair loss), which is thought to impact over 50 million men and over 30 million women in the US alone, is the primary goal of Amplifica, a biopharmaceutical business. The business has discovered and separated distinct signaling molecules that promote hair follicle growth. To assess the safety and effectiveness of its fundamental technology, Amplifica will start clinical studies and secure the necessary regulatory clearances.
Recent Developments
- In January 2024, after the candidate showed promising results in a Phase Ib trial, Hope Medicine began recruiting for a Phase II trial evaluating its monoclonal antibody HMI-115 for androgenetic alopecia.
- In October 2022, a San Diego biotech business called Amplifica Holdings Group raised $11.8 million in its first round of venture capital funding to help balding individuals grow back their hair.
If you have any questions, please feel free to contact us at sales@towardshealthcare.com
Keypoints
- Company Overview
- Locations Subsidiaries/Geographic reach
- Key Executives
- Company Financials
- Patents registered
- SWOT Analysis
- Applications Catered
- Strategic collaborations
- Recent Developments
- Competitive Benchmarking